| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5825375 | Clinical Therapeutics | 2014 | 13 Pages |
Abstract
Once-daily repeated dosing of FF/VI, 100/25 µg, using the ELLIPTA dry powder inhaler was as well tolerated as FF, 100 µg, in this small, selected population of 5- to 11-year-old, mostly white/caucasian children with persistent asthma.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Amanda MBBS, MRCP, FFPM, Sandi RN, Ann BSc (Hons), Melanie BSc (Hons), Lee MSc, Amir MBBS, Rodger PhD,